AstraZeneca PLC 2025 SR
The report highlights AstraZeneca's efforts to improve the health of people, society, and the planet. Key achievements include a 77.5% reduction in Scope 1 and 2 greenhouse gas emissions and a 23% reduction in water use compared to a 2015 baseline. The company also expanded its Healthy Heart Africa programme to include chronic kidney disease, reaching 12.9 million people with elevated blood pressure since 2014. Additionally, AstraZeneca launched the UK's first unsubsidised biomethane plant dedicated to the life sciences sector to provide clean heat for its operations.
Company: AstraZeneca PLC
Sector: Health Care
Country: United Kingdom
Year: 2025
Type: SR
Pages: 58
AstraZeneca PLC
Our Sustainability Impact
The report highlights AstraZeneca's efforts to improve the health of people, society, and the planet. Key achievements include a 77.5% reduction in Scope 1 and 2 greenhouse gas emissions and a 23% reduction in water use compared to a 2015 baseline. The company also expanded its Healthy Heart Africa programme to include chronic kidney disease, reaching 12.9 million people with elevated blood pressure since 2014. Additionally, AstraZeneca launched the UK's first unsubsidised biomethane plant dedicated to the life sciences sector to provide clean heat for its operations.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2025
Reporting Period
Jan 1, 2024 - Dec 31, 2024
Fiscal Year
2024
Published
May 1, 2025
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Sustainable Development Goals
Other Standards
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Renewable Energy
Net Zero Target